A comparison of the efficacy of long-acting β2-agonists: Eformoterol via Turbohaler® and salmeterol via pressurized metered dose inhaler or Accuhaler®, in mild to moderate asthmatics

Respiratory Medicine

Volumn 93, Issue 4, 1999, Pages 236-244

  Campbell, L M ^a   Anderson, T J ^b   Parashchak, M R ^c   Burke, C M ^d   Watson, S A ^e   Turbitt, M L ^e  

^a Southbank Surgery   (United Kingdom)

^b Nethertown Surgery   (United Kingdom)

^c Longford Street Group Practice ^*  (United Kingdom)

^d Royal College of Surgeons in Ireland   (Ireland)

^e Astra Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; SALMETEROL XINAFOATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032922455     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90019-7     Document Type: Article

References (13)

1. Barnes PJ, Barnett AH, Brewis RA et al. Guidelines on the management of asthma. Thorax 1993; 48: S1-S4.
2. Harrison BDW, Nichols JM. Results of two surveys in Norfolk of the use of guidelines on asthma management. Thorax 1995; 50 (Suppl. 20): AS1.
3. Kales A, Beall GN, Bajor GF, Jacobson A, Kales JD. Sleep studies in asthmatic adults: relationship of attacks to sleep stages and time of night. J Allergy 1968; 41: 164-173.
4. 2-adrenocepter stimulants on the isolated trachea and atria of the guinea-pig. Arzneim-Forsch 1976; 26: 839-842.
5. 2-adrenoreceptor stimulants in conscious guinea pigs. Arzneim-Forsch 1976; 26: 1337-1340
6. Linsen VMJ, Brindels HJC, Van Norden JA. A direct comparison of the time of onset of action between inhaled formoterol and salmeterol. Eur Respir J 1993; 6: S591.
7. Van Noord JA, Smeets JJ, Raaijmakers JA, Bommer AM, Maesen FPV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9: 1684-1688.
8. Arvidsson P, Larsson S, Lofdahl CG, Melander B, Wahlander L, Svedmyr N. Formoterol, a new long-acting bronchodilator for inhalation. Eur Respir J 1989; 2: 3256-3330.
9. Ekström T, Ringdal N, Tukiainen P. Formoterol Turbuhaler® 12μg bd improves lung function in asthmatic patients compared with terbutaline and placebo. Eur Respir J 1995; 8 (Suppl. 19): 158S.
10. Anderson GP, Linden A, Rabe KF. Why are long-acting beta-adrenoreceptor agonists long-acting? Eur Respir J 1994; 7: 569-578.
11. Borgström L, Derom E, Ståuhl E, Wåhlin-Boll E, Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 1996; 153: 1636-1640.
12. Lofdahl CG, Andersson L, Bondesson E et al. Salbutamol doses inhaled via a Turbohaler gives a better bronchodilating effect than when given via a pressurised metered dose inhaler. Eur Respir J 1994; 7 (Suppl. 18): PO281.
13. British Thoracic Society, Research Unit of the Royal College of Physicians et al. Guidelines on the management of asthma. Thorax 1997; 52: 1-24.